Crinetics Pharmaceuticals Inc
(CRNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 31,966 | 27,807 | 26,089 | 22,918 | 21,791 |
| Operating Income | -30,888 | -27,807 | -26,089 | -22,918 | -21,791 |
| Other Income | 94 | -44 | -6 | 17 | 150 |
| Pre-tax Income | -30,794 | -27,851 | -26,095 | -22,901 | -21,641 |
| Net Income Continuous | -30,794 | -27,851 | -26,095 | -22,901 | -21,641 |
| Net Income | $-30,794 | $-27,851 | $-26,095 | $-22,901 | $-21,641 |
| EPS Basic Total Ops | -0.68 | -0.73 | -0.70 | -0.69 | -0.62 |
| EPS Basic Continuous Ops | -0.68 | -0.73 | -0.70 | -0.69 | -0.63 |
| EPS Diluted Total Ops | -0.68 | -0.73 | -0.70 | -0.69 | -0.62 |
| EPS Diluted Continuous Ops | -0.68 | -0.73 | -0.70 | -0.69 | -0.63 |
| EBITDA(a) | $-31,545 | $-27,508 | $-25,772 | $-22,611 | $-21,500 |